| Today's Open | $3.05 |
|---|---|
| Previous Close | $3.00 |
| Daily Range | $2.99 - $3.07 |
| 52-Week Range | $2.73 - $8.18 |
| Market Cap | $33.1M |
| P/E Ratio | -1.18 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 828,653 |
| Average Daily Volume | 205,688 |
| Current FY EPS | $0.00 |
Sector
Healthcare
Industry
Drugs
CYCLACEL PHARMACEUTICALS, INC. (CYCC) Description
A development-stage biopharmaceutical company dedicated to the discovery, development and eventual commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Website: http://www.cyclacel.com/
News & Commentary
Cyclacel Announces New Stock Issue
The pharmaceutical company hopes to reap gross proceeds of around $20 million from the offering.Cyclacel Announces Sale of Four Cyclacel Romidepsin-Related Patents to Celgene, Dismissal of All Cla
Cyclacel Announces Sale of Four Cyclacel Romidepsin-Related Patents to Celgene, Dismissal of All Claims in Their Patent LitigationCYCC's Top Competitors
(1.33%)
(0.63%)
(2.44%)
(-0.50%)